Label-free metabolic imaging of non-alcoholic-fatty-liver-disease (NAFLD) liver by volumetric dynamic optical coherence tomography

被引:10
|
作者
Mukherjee, Pradipta [1 ]
Fukuda, Shinichi [2 ,3 ]
Lukmanto, Donny [3 ]
Yamashita, Toshiharu [4 ]
Okada, Kosuke [5 ]
Makita, Shuichi [1 ]
Abd El-Sadek, Ibrahim [1 ,6 ]
Miyazawa, Arata [7 ]
Zhu, Lida [1 ]
Morishita, Rion [1 ]
Lichtenegger, Antonia [1 ,8 ]
Oshika, Tetsuro [2 ]
Yasuno, Yoshiaki [1 ]
机构
[1] Univ Tsukuba, Computat Opt Grp, Tsukuba, Ibaraki, Japan
[2] Univ Tsukuba, Fac Med, Dept Ophthalmol, Tsukuba, Ibaraki, Japan
[3] Univ Tsukuba, Fac Med, Dept Adv Vis Sci, Tsukuba, Ibaraki, Japan
[4] Univ Tsukuba, Grad Sch Comprehens Human Sci, Lab Regenerat Med & Stem Cell Biol, Tsukuba, Ibaraki, Japan
[5] Univ Tsukuba, Fac Med, Div Med Sci, Tsukuba, Ibaraki, Japan
[6] Damietta Univ, Fac Sci, Dept Phys, Dumyat 34517, Egypt
[7] Sky Technol Inc, Tsukuba, Ibaraki, Japan
[8] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria
基金
日本科学技术振兴机构; 奥地利科学基金会; 日本学术振兴会;
关键词
LIPID DROPLETS; NONALCOHOLIC STEATOHEPATITIS; INTRACELLULAR MOTION; HEPATIC-FIBROSIS; CONTRAST; PROGRESSION; MOTILITY; ZONATION; MODELS;
D O I
10.1364/BOE.461433
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Label-free metabolic imaging of non-alcoholic fatty liver disease (NAFLD) mouse liver is demonstrated ex vivo by dynamic optical coherence tomography (OCT). The NAFLD mouse is a methionine choline-deficient (MCD)-diet model, and two mice fed the MCD diet for 1 and 2 weeks are involved in addition to a normal-diet mouse. The dynamic OCT is based on repeating raster scan and logarithmic intensity variance (LIV) analysis that enables volumetric metabolic imaging with a standard-speed (50,000 A-lines/s) OCT system. Metabolic domains associated with lipid droplet accumulation and inflammation are clearly visualized three-dimensionally. Particularly, the normal-diet liver exhibits highly metabolic vessel-like structures of peri-vascular hepatic zones. The 1-week MCD-diet liver shows ring-shaped highly metabolic structures formed with lipid droplets. The 2-week MCD-diet liver exhibits fragmented vessel-like structures associated with inflammation. These results imply that volumetric LIV imaging is useful for visualizing and assessing NAFLD abnormalities.
引用
收藏
页码:4071 / 4086
页数:16
相关论文
共 50 条
  • [31] Metabolic syndrome, non-alcoholic fatty liver disease, and hepatocellular carcinoma
    Serradilla Martin, Mario
    Oliver Guillen, Jose Ramon
    Palomares Cano, Ana
    Ramia Angel, Jose Manuel
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2020, 112 (02) : 133 - 138
  • [32] Non-alcoholic fatty liver disease: Further expression of the metabolic syndrome
    Tarantino, Giovanni
    Saldalamacchia, Gennaro
    Conca, Paolo
    Arena, Adriano
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (03) : 293 - 303
  • [33] Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
    Nier, Anika
    Huber, Yvonne
    Labenz, Christian
    Michel, Maurice
    Bergheim, Ina
    Schattenberg, Joern M.
    NUTRIENTS, 2020, 12 (03)
  • [34] Non-alcoholic fatty liver disease (NAFLD) as a neglected metabolic companion of psychiatric disorders: common pathways and future approaches
    Óscar Soto-Angona
    Gerard Anmella
    María José Valdés-Florido
    Nieves De Uribe-Viloria
    Andre F. Carvalho
    Brenda W. J. H. Penninx
    Michael Berk
    BMC Medicine, 18
  • [35] Non-alcoholic fatty liver disease (NAFLD) as a neglected metabolic companion of psychiatric disorders: common pathways and future approaches
    Soto-Angona, Oscar
    Anmella, Gerard
    Valdes-Florido, Maria Jose
    De Uribe-Viloria, Nieves
    Carvalho, Andre F.
    Penninx, Brenda W. J. H.
    Berk, Michael
    BMC MEDICINE, 2020, 18 (01)
  • [36] The Importance of the Fatty Acid Transporter L-Carnitine in Non-Alcoholic Fatty Liver Disease (NAFLD)
    Savic, Dragana
    Hodson, Leanne
    Neubauer, Stefan
    Pavlides, Michael
    NUTRIENTS, 2020, 12 (08) : 1 - 17
  • [37] Role of microRNA in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a comprehensive review
    Changez, Mah I. Kan
    Mubeen, Maryam
    Zehra, Monezahe
    Samnani, Inara
    Rasool, Aniqa Abdul
    Mohan, Anmol
    Ul Wara, Um
    Tejwaney, Usha
    Kumar, Vikash
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2023, 51 (09)
  • [38] Impact renaming non-alcoholic fatty liver disease to metabolic associated fatty liver disease in prevalence, characteristics and risk factors
    Huang, Xin-Juan
    Yin, Man
    Zhou, Bing-Qian
    Tan, Xin-Yun
    Xia, Yuan-Qin
    Qin, Chun-Xiang
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (08) : 985 - 1000
  • [39] Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD)
    Roderburg, Christoph
    Krieg, Sarah
    Krieg, Andreas
    Demir, Muenevver
    Luedde, Tom
    Kostev, Karel
    Loosen, Sven H.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [40] Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD)
    Christoph Roderburg
    Sarah Krieg
    Andreas Krieg
    Münevver Demir
    Tom Luedde
    Karel Kostev
    Sven H. Loosen
    European Journal of Medical Research, 28